Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Do We Still Need Office Visits?

Like many primary care practices, after a hasty transition to a year of phone calls and video visits, my practice is slowly transitioning back to “normal,” meaning that we are now seeing more patients in person than by video. However, as I reflect on the past year, I wonder how central this notion of the […]

What’s Happening With the Medicare Drug-Price Negotiation Lawsuits?

Over the past year, drugmakers and lobbyists have filed 10 different lawsuits against the federal government’s efforts to lower prescription drug costs via the Medicare Drug Price Negotiation Program. It’s still early days for these cases, but so far the government has won “every substantive motion,” Zachary Baron, JD, of the O’Neill Institute for National […]

Common antibiotic found useful in accelerating recovery in tuberculosis patients

Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a regimen of at least six months of antimicrobial drugs, and drug-resistant TB is an increasing public health threat. Even after the traces of […]

Why Does Everyone Seem To Have The Flu Right Now?

visualspace via Getty Images Influenza cases are definitely more prominent this year, and experts have a few theories. If you suspected this flu season is rougher than previous ones, you’re not imagining it. Last season, flu activity had already peaked and was on the downfall by early January. This year, influenza continues to surge across […]

Healthy diet early in life seems to protect against inflammatory bowel disease

Having a high dietary intake of fish and vegetables at 1 year of age, and a low intake of sugar beverages, seems to protect against inflammatory bowel disease. These are the findings of a study with more than 80,000 children conducted at the University of Gothenburg. The global rise in inflammatory bowel disease (IBD), which […]

Clinical Challenges: Using Pola-R-CHP for Diffuse Large B-Cell Lymphoma

Earlier this year, the FDA approved a new frontline option for patients with diffuse large B-cell lymphoma (DLBCL): the antibody-drug conjugate polatuzumab vedotin (Polivy) in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R-CHP). Combination chemotherapy involving rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) — and before that, CHOP alone — has been the established option […]

Regulation Gap Persists in OTC Eye Care Products

It’s been a bad year for over-the counter (OTC) eye care products and their consumers, with serial government warnings and company recalls of ocular washes, drops, tears, and ointment. And the current state of the OTC industry has U.S. ophthalmologists worried on two fronts, according to a viewpoint overview in JAMA Ophthalmology. “On one side, […]

DBN Health News